Login / Signup

Effect of beta-blocker therapy on the response to mavacamten in patients with symptomatic obstructive hypertrophic cardiomyopathy.

Matthew T WheelerDaniel JacobyPerry M ElliottSara SaberiSheila M HegdeNeal K LakdawalaJonathan MyersAmy J SehnertJay M EdelbergWanying LiIacopo Olivotto
Published in: European journal of heart failure (2022)
and other heart rate-dependent measures, but had minimal impact on heart-rate independent measures. This article is protected by copyright. All rights reserved.
Keyphrases
  • heart rate
  • hypertrophic cardiomyopathy
  • heart rate variability
  • left ventricular
  • blood pressure
  • heart failure
  • bone marrow
  • cell therapy
  • angiotensin ii